FDA to soon decide on second round of Omicron-tailored boosters

The U.S. Food and Drug Administration is close to making a decision on authorization of a second dose of updated COVID-19 vaccine boosters for high-risk people, the Wall Street Journal reported on Tuesday, citing sources.